Articolul precedent |
Articolul urmator |
724 10 |
Ultima descărcare din IBN: 2023-10-19 11:55 |
Căutarea după subiecte similare conform CZU |
547-326+542 (1) |
Organic chemistry (484) |
Practical laboratory chemistry. Preparative and experimental chemistry (138) |
SM ISO690:2012 RUSNAC, Anna, RUSNAC, Roman, PETRENKO, Peter A., CHUMAKOV, Yurii, GULYA, Aurelian. Structure of complex copper with 4-benzoyl-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one N(4)-cyclohexylthiosemicarbazone. In: Materials Science and Condensed Matter Physics, Ed. 9, 25-28 septembrie 2018, Chișinău. Chișinău, Republica Moldova: Institutul de Fizică Aplicată, 2018, Ediția 9, p. 131. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Materials Science and Condensed Matter Physics Ediția 9, 2018 |
||||||
Conferința "International Conference on Materials Science and Condensed Matter Physics" 9, Chișinău, Moldova, 25-28 septembrie 2018 | ||||||
|
||||||
CZU: 547-326+542 | ||||||
Pag. 131-131 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Thiosemicarbazones are an important class of organic compound boThfor chemistry and pharmacology. The most famous and distinguishing features of these compounds are their great variety of pharmacological properties. These biological activities are believed to be intensely related to their ability to form the stable complexes wiTha variety of metals. In addition, it is found that lipophilicity controlling the rate of entry of molecules into the cell may be enhanced by N(4)-substituted thiosemicarbazide. The aim of this work is the synthesis, X-ray characterization of copper complexes wiTh4-benzoyl-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one N(4)-cyclohexylthiosemicarbazone and study their biological properties. The Cu(II) atom exhibits a distorted square-planar geometry involving the tridentate thiosemicarbazone ligand, Cl and Br atoms in I and II respectively. The synthesized compounds show the antimicrobial activity Staphylococcus aureus CMI- 0,25 mg/mL; and antifungal activity Candida albicans - CMI- 0,125 mg/mL |
||||||
|